295 related articles for article (PubMed ID: 17046188)
1. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.
Cheng WC; Ng KM; Chan KK; Mok VK; Cheung BK
Forensic Sci Int; 2007 Jul; 170(1):51-8. PubMed ID: 17046188
[TBL] [Abstract][Full Text] [Related]
2. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
3. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
[TBL] [Abstract][Full Text] [Related]
4. Drugs in oral fluid in randomly selected drivers.
Drummer OH; Gerostamoulos D; Chu M; Swann P; Boorman M; Cairns I
Forensic Sci Int; 2007 Aug; 170(2-3):105-10. PubMed ID: 17658711
[TBL] [Abstract][Full Text] [Related]
5. The incidence of drugs of impairment in oral fluid from random roadside testing.
Chu M; Gerostamoulos D; Beyer J; Rodda L; Boorman M; Drummer OH
Forensic Sci Int; 2012 Feb; 215(1-3):28-31. PubMed ID: 21665392
[TBL] [Abstract][Full Text] [Related]
6. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
[TBL] [Abstract][Full Text] [Related]
7. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
[TBL] [Abstract][Full Text] [Related]
9. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
Davey J; Leal N; Freeman J
Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases.
Choi H; Baeck S; Jang M; Lee S; Choi H; Chung H
Forensic Sci Int; 2012 Feb; 215(1-3):81-7. PubMed ID: 21377815
[TBL] [Abstract][Full Text] [Related]
11. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
[TBL] [Abstract][Full Text] [Related]
13. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
[TBL] [Abstract][Full Text] [Related]
14. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
Khiabani HZ; Mørland J; Bramness JG
Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid.
Gjerde H; Normann PT; Christophersen AS; Mørland J
Forensic Sci Int; 2011 Jul; 210(1-3):221-7. PubMed ID: 21482055
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the Cozart DDS oral fluid collection device.
Speedy T; Baldwin D; Jowett G; Gallina M; Jehanli A
Forensic Sci Int; 2007 Aug; 170(2-3):117-20. PubMed ID: 17624706
[TBL] [Abstract][Full Text] [Related]
17. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges.
Verstraete AG
Forensic Sci Int; 2005 Jun; 150(2-3):143-50. PubMed ID: 15944054
[TBL] [Abstract][Full Text] [Related]
18. Can the prevalence of high blood drug concentrations in a population be estimated by analysing oral fluid? A study of tetrahydrocannabinol and amphetamine.
Gjerde H; Verstraete A
Forensic Sci Int; 2010 Feb; 195(1-3):153-9. PubMed ID: 20045272
[TBL] [Abstract][Full Text] [Related]
19. Performance of a point-of-care device for oral fluid ketamine evaluated by a liquid chromatography-tandem mass spectrometry method.
Tsui TK; Chan AS; Lo CW; Wong A; Wong RC; Ho CS
J Anal Toxicol; 2012 Apr; 36(3):210-6. PubMed ID: 22417838
[TBL] [Abstract][Full Text] [Related]
20. Legal issues in oral fluid testing.
Kadehjian L
Forensic Sci Int; 2005 Jun; 150(2-3):151-60. PubMed ID: 15944055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
